Fabrication and Characterisation of Lavender Oil and Plant Phospholipid Based Sumatriptan Succinate Hybrid Nano Lipid Carriers
Publish place: Pharmaceutical and Biomedical Research، Vol: 6، Issue: 1
Publish Year: 1399
نوع سند: مقاله ژورنالی
زبان: English
View: 67
This Paper With 14 Page And PDF Format Ready To Download
- Certificate
- من نویسنده این مقاله هستم
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
JR_PBRE-6-1_008
تاریخ نمایه سازی: 10 دی 1402
Abstract:
Background: Nanostructured lipid carriers (NLCs) of sumatriptan succinate (SS) were prepared by using lavender oil. In ancient days, lavender oil was used for the treatment of a migraine. The natural anti-migraine agent, lavender oil, combined with an anti-migraine drug such as SS in a nano-formulation, will be a practical alternative approach in migraine therapy.
Objective: NLCs of sumatriptan succinate were fabricated by using a natural anti-migraine oil (lavender oil), LECIVA-S۷۰, which is a specialized grade for liposomal dermatological preparation and designed for emulsion, fat infusions, nutraceutical formulations, and parenteral use. It contains ۷۰% phosphatidylcholine, which is not generally present in the regular soy lecithin.
Methods: The central composite design technique was used to examine the relationship between independent variables and responses such as lavender oil and LECIVA-S۷۰. The dependent variables were Z-average (R۱), polydispersity index (R۲), and % entrapment efficiency (R۳). The NLCs were prepared with the double emulsification technique. The Fourier transform infrared spectroscopy, X-ray diffraction, and differential scanning calorimetry analyzed the drug excipient compatibility profile. The developed NLCs were characterized for particle size by using Mastersizer, Zetasizer, and transmission electron microscopy. The membrane diffusion technique studied the in vitro drug release profile.
Results: The mean±SD size of the NLCs ranged from ۴۱۱.۴±۳۱۱.۱ d.nm to ۳۹۸.۸±۲۴۲.۶ d.nm. The best formulation (SNE۹) demonstrated an average diameter of ۳۹۸.۸±۲۴۲.۶ d.nm, with the PDI of ۰.۲۱۶, and zeta potential of ۱۷.۱۸ mV.
Conclusion: The optimized formula demonstrated the narrow size range, a satisfactory zeta potential, high drug loading, and reproducible drug release profile. The NLCs successfully retained the aroma of the lavender oil. According to ANOVA, the polydispersity index (R۲) is significant with the central composite design.
Keywords:
Nanostructured lipid carriers (NLCs) , Zetasizer , Zeta potential , Transmission electron microscopy (TEM)
Authors
Reeta
Rayat-Bahra Institute of Pharmacy, Rayat-Bahra University, Punjab, India
Rashid Mehmood
School of Materials Science and Engineering, UNSW Sydney, NSW, Australia
Maria John Newton Amaldoss
School of Materials Science and Engineering, UNSW Sydney, NSW, Australia
مراجع و منابع این Paper:
لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :